Atlas Trials

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

Clinical trial NCT04143594 · COMPLETED

Trial details

NCT number
NCT04143594
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-1-infection
Start date
2019-11-22
Primary completion
2021-10-05
Enrollment
183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.